SEM
Select Medical·NYSE
--
--(--)
--
--(--)
3.96 / 10
Netural
Fund flow evaluation is positive (7.93/10), reflecting net inflows across most sizes, though large-cap flows show mild resistance. Analyst consensus is overwhelmingly Buy, but historical prediction accuracy is poor (0.0% win rate). Together, strong money inflows and bullish analyst views offset some technical concerns, yet the lack of proven analyst reliability limits conviction.
Fund Flow Rating
Analyst RatingBuy
Wall Street Opinions
Buy
Strong Buy
0%
Buy
100%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-10-08
InstitutionRBC Capital
Times predicted3
Historical Win Rate0.0%
Is money flowing into or out of SEM?
- SEM holds a Bearish analyst rating, with 100% of experts assigning a Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 3.96/10 (Netural).
